News tagged with dipeptidyl peptidase


Linagliptin noninferior to glimepiride in type 2 diabetes

(HealthDay) -- A new drug for type 2 diabetes causes significantly less weight gain and may carry lower risks for hypoglycemia (low blood sugar), heart attack and stroke than standard medications, a new study indicates.

Diabetes created Jun 28, 2012 | popularity not rated yet | comments 0